Prelude Capital Management’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Buy
35,330
+14,710
+71% +$139K 0.03% 691
2026
Q1
$177K Sell
20,620
-14,039
-41% -$126K 0.01% 941
2025
Q4
$306K Buy
34,659
+16,356
+89% +$189K 0.02% 784
2025
Q3
$243K Buy
18,303
+4,259
+30% +$53.3K 0.02% 843
2025
Q2
$192K Sell
14,044
-2,956
-17% -$39.8K 0.02% 829
2025
Q1
$234K Buy
+17,000
New +$248K 0.02% 835

Other funds holding ARDT

Prelude Capital Management's ARDT Position: Q2 2026 in Review

Prelude Capital Management increased its Ardent Health (ARDT) stake by 71% in Q2 2026, buying an estimated $139K and bringing the position to 35,330 shares worth $348K. The position accounts for 0.03% of the portfolio, ranked #691.

Prelude Capital Management first reported a position in ARDT in Q1 2025 and has held it in 6 quarters since. 138 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Prelude Capital Management held 35,330 shares of Ardent Health worth $348K as of Q2 2026.
  • Prelude Capital Management bought 14,710 Ardent Health shares in Q2 2026, an estimated $139K.
  • Ardent Health made up 0.03% of Prelude Capital Management's portfolio in Q2 2026, its #691 holding.
  • Prelude Capital Management first reported a position in Ardent Health in Q1 2025 and has held it in 6 quarters since.
  • 138 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.